Versatrim, LLC – Trademark Portfolio
Entity Type: 16
Versatrim, LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 19 (Building Materials) — 9 filings in this category. The portfolio also extends into Class 20 (Furniture) across 7 Nice Classification classes. Currently, 8 trademarks are registered and 3 are pending. Notable registered marks include VERSACAP, VERSAEDGE, VERSAFLEX, VERSATRIM, and VERSATRACK. The owner is based in Henderson, NC.
101 Eastern Minerals Rd
Henderson, NC 27537
Showing of trademarks Trademarks
Trademark Classifications
Versatrim, LLC's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Versatrim, LLC have?
Versatrim, LLC has 11 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 pending.
What trademark classes does Versatrim, LLC file in?
Versatrim, LLC files trademarks across 7 Nice Classification classes. The most active classes are Class 19 (Building Materials), Class 20 (Furniture), Class 16 (Paper Goods), Class 17 (Rubber Goods), Class 40 (Treatment & Processing). Class 19 covers building materials (non-metallic); non-metallic rigid pipes for building.
What are Versatrim, LLC's most well-known trademarks?
Versatrim, LLC's registered trademark portfolio includes well-known marks such as VERSACAP, VERSAEDGE, VERSAFLEX, VERSATRIM, and VERSATRACK. These are among 8 currently registered trademarks in the portfolio.
What is Versatrim, LLC's trademark registration success rate?
Versatrim, LLC has a 100% trademark registration rate, with 8 out of 8 resolved applications resulting in successful registration. Currently, 3 applications are pending review.